companydata.dkOrganon Denmark ApS: Financial statements 2023
CVR: 41193093
Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 63,900,000 and a net result of DKK 2,924,000 compared with DKK 2,139,000 the year before. That is an increase of 3.1% compared with the year before. The profit margin was 4.6%. Equity amounted to DKK 29,482,000. The solvency ratio was 65.2%. The company had 16 employees in the financial year.
- Revenue
- 63,900,000 kr.
- Gross Profit
- 11,902,000 kr.
- Profit/Loss
- 2,924,000 kr.
- Equity
- 29,482,000 kr.
- Total Assets
- 45,249,000 kr.
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 63.9 mio. | 11.9 mio. | 2.9 mio. | 29.5 mio. | 16 |
| 2022 | 62 mio. | 11.9 mio. | 2.1 mio. | 26.6 mio. | 16 |
| 2021 | 51 mio. | 8.6 mio. | 857 t. | 24.4 mio. | 13 |
| 2020 | 49.2 mio. | 4.4 mio. | 1.3 mio. | 22.7 mio. | 5 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Organon Denmark ApS has published its annual report for 2022. Revenue came to DKK 61,971,000, and the net result was DKK 2,139,000.
About Organon Denmark ApS
Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karl Johan Sundt, Sofia Raquel Paulos Ferreira Alves da Silva and Anne Bitzer. The company is owned by OBS Human Health Holding B.V.. In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity amounted to DKK 31,049,000.